Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950133-05-000961
Filing Date
2005-03-10
Accepted
2005-03-10 14:17:30
Documents
13
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 ADVANCIS PHARMACEUTICAL CORPORATION'S FORM 10-K w04692e10vk.htm 10-K 907189
2 EX-10.41 w04692exv10w41.htm EX-10.41 145240
3 EX-10.42 w04692exv10w42.htm EX-10.42 15169
4 EX-10.43 w04692exv10w43.htm EX-10.43 412237
5 EX-10.44 w04692exv10w44.htm EX-10.44 64602
6 EX-10.45 w04692exv10w45.htm EX-10.45 64859
7 EX-23.1 w04692exv23w1.htm EX-23.1 1073
8 EX-31.1 w04692exv31w1.htm EX-31.1 7212
9 EX-31.2 w04692exv31w2.htm EX-31.2 7199
10 EX-32.1 w04692exv32w1.htm EX-32.1 2117
11 EX-32.2 w04692exv32w2.htm EX-32.2 2110
12 GRAPHIC w04692w0469200.gif GRAPHIC 15449
13 GRAPHIC w04692w0469201.gif GRAPHIC 92007
  Complete submission text file 0000950133-05-000961.txt   1739236
Mailing Address
Business Address 20425 SENECA MEADOWS PARKWAY GERMANTOWN MD 20878 (301) 944-6600
ADVANCIS PHARMACEUTICAL CORP (Filer) CIK: 0001161924 (see all company filings)

EIN.: 522208264
Type: 10-K | Act: 34 | File No.: 000-50414 | Film No.: 05671814
SIC: 2834 Pharmaceutical Preparations